Mesenchymal stem cells not checked

Red de Terapia Celular

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
1 active
2 in total · 1 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Lupus Nephritis, Lupus Erythematosus
Main trialPhase 2
“The purpose of this study is to evaluate the safety and efficacy of mesenchymal stem cells (MSCs) obtained from bone marrow for the treatment of adults with active proliferative lupus nephritis. The objective of this study is to evaluate the efficacy of mesenchymal stem cells (MSCs) in achieving a full or partial response in the treatment of Lupus Nephritis (LN) during its induction period.”In the company’s words, NCT03673748 on ClinicalTrials.gov

Other drugs for Lupus Nephritis

All 45 drugs for Lupus Nephritis

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 2Recruiting Dec 2027 Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells
Phase 2Completed 28 Oct 2021 Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stem Cells
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Mesenchymal stem cells

Following is part of Solo: you see every change to Mesenchymal stem cells the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in